Yang L - Search Results

1

Correction: Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma.

Yang L, Tan Y, Shi J, Zhao Y, Zhu Y, Hu Y, Pan W, Ye Y, He J, Zheng W, Sun J, Cai Z, Huang H, Luo Y. Yang L, et al. Bone Marrow Transplant. 2020 Oct;55(10):2056. doi: 10.1038/s41409-020-0962-x. Bone Marrow Transplant. 2020. PMID: 32541688 Free PMC article.

2

Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma.

Yang L, Tan Y, Shi J, Zhao Y, Zhu Y, Hu Y, Pan W, Ye Y, He J, Zheng W, Sun J, Cai Z, Huang H, Luo Y. Yang L, et al. Bone Marrow Transplant. 2018 Oct;53(10):1340-1344. doi: 10.1038/s41409-018-0184-7. Epub 2018 Apr 30. Bone Marrow Transplant. 2018. PMID: 29712994 Free PMC article. No abstract available.

3

Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report.

Jin M, Hu Y, Wu W, Luo Y, Tan Y, Yu J, Jin A, Yang L, Huang H, Wei G. Jin M, et al. Among authors: yang l. BMC Cancer. 2019 Mar 18;19(1):242. doi: 10.1186/s12885-019-5464-0. BMC Cancer. 2019. PMID: 30885156 Free PMC article.

4

Correction to: Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report.

Jin M, Hu Y, Wu W, Luo Y, Tan Y, Yu J, Jin A, Yang L, Huang H, Wei G. Jin M, et al. Among authors: yang l. BMC Cancer. 2019 May 23;19(1):486. doi: 10.1186/s12885-019-5626-0. BMC Cancer. 2019. PMID: 31122200 Free PMC article.

5

CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutations.

Jin A, Feng J, Wei G, Wu W, Yang L, Xu H, Zhang Y, Cui J, Chang AH, Hu Y, Huang H. Jin A, et al. Among authors: yang l. Bone Marrow Transplant. 2020 Apr;55(4):717-721. doi: 10.1038/s41409-020-0807-7. Epub 2020 Jan 31. Bone Marrow Transplant. 2020. PMID: 32005917

6

Factors Associated with Costs in Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies.

Zhu F, Wei G, Zhang M, Zhao H, Wu W, Yang L, Hu Y, Huang H. Zhu F, et al. Among authors: yang l. Cell Transplant. 2020 Jan-Dec;29:963689720919434. doi: 10.1177/0963689720919434. Cell Transplant. 2020. PMID: 32314613 Free PMC article.

7

A Novel Strategy for the Prevention of Hepatitis B Virus-Related Hepatitis Following Allogeneic Hematopoietic Stem Cell Transplantation from Hepatitis B Surface Antigen-Positive Donors.

Wu Y, Shi J, Tan Y, Zhao Y, Yu J, Lai X, Yang L, Huang H, Luo Y. Wu Y, et al. Among authors: yang l. Biol Blood Marrow Transplant. 2020 Sep;26(9):1719-1728. doi: 10.1016/j.bbmt.2020.05.004. Epub 2020 May 17. Biol Blood Marrow Transplant. 2020. PMID: 32434055 Free article.

8

Idiopathic thrombocytopenic purpura treatment in a relapsed/refractory multiple myeloma patient after chimeric antigen receptor T cell therapy.

Qiu L, Zhu F, Wei G, Wu W, Yang L, Hu Y, Huang H. Qiu L, et al. Among authors: yang l. Regen Ther. 2020 May 15;14:271-274. doi: 10.1016/j.reth.2020.03.005. eCollection 2020 Jun. Regen Ther. 2020. PMID: 32455157 Free PMC article.

9

Prophylactic modified donor lymphocyte infusion after low-dose ATG-F-based haploidentical HSCT with myeloablative conditioning in high-risk acute leukemia: a matched-pair analysis.

Yang L, Tan Y, Shi J, Zhao Y, Yu J, Hu Y, Lai X, Yang Y, Huang H, Luo Y. Yang L, et al. Among authors: yang y. Bone Marrow Transplant. 2021 Mar;56(3):664-672. doi: 10.1038/s41409-020-01088-7. Epub 2020 Oct 19. Bone Marrow Transplant. 2021. PMID: 33077902

10

Preemptive low-dose interleukin-2 or DLI for late-onset minimal residual disease in acute leukemia or myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation.

Yuan XL, Tan YM, Shi JM, Zhao YM, Yu J, Lai XY, Yang LX, Huang H, Luo Y. Yuan XL, et al. Ann Hematol. 2021 Feb;100(2):517-527. doi: 10.1007/s00277-020-04326-6. Epub 2020 Oct 31. Ann Hematol. 2021. PMID: 33128124 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57,231 results

Search Page

Filters